M 253 Pill - white round, 11mm
Pill with imprint M 253 is White, Round and has been identified as Acyclovir 400 mg. It is supplied by Mylan Pharmaceuticals Inc.
Acyclovir is used in the treatment of Cold Sores; Herpes Simplex (HSV); Herpes Simplex Encephalitis; Herpes Simplex - Congenital; Herpes Simplex, Suppression and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Acyclovir 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 253
Acyclovir
- Imprint
- M 253
- Strength
- 400 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Purine nucleosides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
povidone,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-0253 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0448 (Discontinued) | UDL Laboratories Inc. |
| 66267-0007 (Discontinued) | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "M 253"
More about acyclovir
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (188)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: purine nucleosides
- Breastfeeding
Patient resources
- Acyclovir drug information
- Acyclovir injection
- Acyclovir (Buccal mucosa) (Advanced Reading)
- Acyclovir (Oral, Intravenous) (Advanced Reading)
Other brands
Professional resources
- Acyclovir monograph
- Acyclovir Capsules (FDA)
- Acyclovir IV Infusion (FDA)
- Acyclovir Injection (FDA)
- Acyclovir Oral Suspension (FDA)
- Acyclovir Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.